Erectile dysfunction and coronary disease: Evaluating the link


      Erectile dysfunction (ED) is common, affecting 40% of men over 40 years of age (so-called 40 over 40) and 1 in 3 men over 70 years of age. It is predominantly a vascular condition, often preceding a cardiovascular event by 3–5 years. ED is associated as a consequence with acute coronary syndromes and increased cardiovascular and all-cause mortality. Its early identification therefore offers a window of opportunity for cardiovascular risk reduction. ED has for many a devastating impact on a couple's relationship. Its treatment is often successful, maintaining quality of life in the middle aged and elderly. ED should always be queried as part of the ongoing health care worker and patient relationship – its early detection may prevent early death.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ayta I.A.
        • McKinlay J.B.
        • Krane R.J.
        The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences.
        BJU Int. 1999; 84: 50-56
        • Feldman H.A.
        • Johannes C.B.
        • Derby C.A.
        • et al.
        Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study.
        Prev Med. 2000; 30: 328-338
        • Selvin E.
        • Burnett A.L.
        • Platz E.A.
        Prevalence and risk factors for erectile dysfunction in the US.
        Am J Med. 2007; 120: 151-157
        • Solomon H.
        • Man J.W.
        • Jackson G.
        Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator.
        Heart. 2003; 89: 251-253
        • Jackson G.
        • Boon N.
        • Eardley I.
        • et al.
        Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus.
        Int J Clin Pract. 2010; 64: 848-857
        • Jackson G.
        Erectile dysfunction: a marker of silent coronary artery disease.
        Eur Heart J. 2006; 27: 2613-2614
        • Jackson G.
        • Rosen R.C.
        • Kloner R.A.
        • Kostis J.B.
        The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.
        J Sex Med. 2006; 3 ([discussion 36]): 28-36
        • Hatzimouratidis K.
        • Amar E.
        • Eardley I.
        • et al.
        Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.
        Eur Urol. 2010; 57: 804-814
        • Gupta B.P.
        • Murad M.H.
        • Clifton M.M.
        • Prokop L.
        • Nehra A.
        • Kopecky S.L.
        The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis.
        Arch Intern Med. 2011; 171: 1797-1803
        • Jackson G.
        The importance of risk factor reduction in erectile dysfunction.
        Curr Urol Rep. 2007; 8: 463-466
        • Bohm M.
        • Baumhakel M.
        • Teo K.
        • Sleight P.
        • Probstfield J.
        • Gao P.
        • et al.
        Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ongoing Telmisartan alone and in combination with Ramipril Global Endpoint Trial/Telmisartan randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) Trials.
        Circulation. 2010; 121: 1439-1446
        • Montorsi P.
        • Ravagnani P.M.
        • Galli S.
        • et al.
        Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient.
        Eur Urol. 2006; 50: 721-731
        • Kirby M.
        • Jackson G.
        • Betteridge J.
        • Friedli K.
        Is erectile dysfunction a marker for cardiovascular disease?.
        Int J Clin Pract. 2001; 55: 614-618
        • Hodges L.D.
        • Kirby M.
        • Solanki J.
        • O’Donnell J.
        • Brodie D.A.
        The temporal relationship between erectile dysfunction and cardiovascular disease.
        Int J Clin Pract. 2007; 61: 2019-2025
        • Inman B.A.
        • Sauver J.L.
        • Jacobson D.J.
        • et al.
        A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.
        Mayo Clin Proc. 2009; 84: 108-113
        • Dong J.Y.
        • Zhang Y.H.
        • Qin L.Q.
        Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies.
        J Am Coll Cardiol. 2011; 58: 1378-1385
        • Jones T.H.
        • Arver S.
        • Behre H.M.
        • et al.
        Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).
        Diabetes Care. 2011; 34: 828-837
        • Jackson G.
        • Montorsi P.
        • Adams M.A.
        • et al.
        Cardiovascular aspects of sexual medicine.
        J Sex Med. 2010; 7: 1608-1626
        • Jackson G.
        • Padley S.
        Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs.
        Int J Clin Pract. 2008; 62: 973-976